FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and is intended for instillation in eye for treating eye diseases. Ophthalmic composition contains Cyclosporine as an active ingredient, polyethoxylated castor oil or polyethoxylated hydrogenated castor oil as Cyclosporine solubilising agent and phosphate buffer. This composition is made in the form of a nanoemulsion with particle diameter of 100 nm or less, prepared by simple mixing.
EFFECT: invention provides a composition which does not cause eye irritation, is physiochemically stable and has a long shelf life.
10 cl, 13 tbl, 4 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC NANOEMULSION COMPOSITION CONTAINING CYCLOSINO AND PREPARATION METHOD THEREOF | 2014 |
|
RU2683271C2 |
| OPHTHALMIC COMPOSITION CONTAINING CYCLOSPORINE AND TREHALOSE | 2015 |
|
RU2700927C2 |
| CLOBETAZOLE COMPOSITION IN THE FORM OF OIL-IN-WATER NANO-EMULSION | 2018 |
|
RU2759901C2 |
| OPHTHALMOLOGICAL COMPOSITIONS | 2017 |
|
RU2756758C2 |
| CYCLOSPORINE SUSPENSIONS A OF FORM 2 | 2012 |
|
RU2641963C2 |
| ARTIFICIAL TEARS AND THERAPEUTIC APPLICATION | 2010 |
|
RU2589837C2 |
| AQUEOUS OPHTHALMIC SOLUTION BASED ON CYCLOSPORIN A | 2013 |
|
RU2634267C2 |
| ANDROGEN COMPOSITION FOR TREATING OPHTHALMIC CONDITIONS | 2012 |
|
RU2599036C2 |
| MICROEMULSION COMPOSITIONS | 2019 |
|
RU2787998C1 |
| PEGYLATED LIPID NANOPARTICLE WITH A BIOACTIVE LIPOPHILIC COMPOUND | 2016 |
|
RU2737893C2 |
